Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
2.600
-0.020 (-0.76%)
Nov 18, 2025, 4:00 PM EST - Market closed
Definitive Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 242.28 | 252.2 | 251.42 | 222.65 | 166.15 | 118.32 | Upgrade | |
Revenue Growth (YoY) | -5.30% | 0.31% | 12.92% | 34.00% | 40.43% | 38.38% | Upgrade |
Cost of Revenue | 38.98 | 40.68 | 34.74 | 25.87 | 19.42 | 11.09 | Upgrade |
Gross Profit | 203.3 | 211.52 | 216.68 | 196.79 | 146.73 | 107.23 | Upgrade |
Selling, General & Admin | 127.68 | 133.07 | 153.4 | 141.15 | 89.25 | 48.7 | Upgrade |
Research & Development | 33.8 | 36.52 | 42.44 | 34.89 | 18.57 | 11.06 | Upgrade |
Amortization of Goodwill & Intangibles | 19.33 | 14.05 | 12.74 | 16.76 | 21.27 | 19.38 | Upgrade |
Operating Expenses | 216.83 | 221.26 | 247.59 | 232.94 | 167.76 | 119.34 | Upgrade |
Operating Income | -13.54 | -9.74 | -30.91 | -36.15 | -21.03 | -12.11 | Upgrade |
Interest Expense | -11.93 | -14.84 | -15.2 | -11.2 | -25.9 | -36.49 | Upgrade |
Interest & Investment Income | 8.68 | 14.59 | 13.64 | 2.79 | 0.03 | - | Upgrade |
Currency Exchange Gain (Loss) | -1.49 | - | - | - | - | -0.22 | Upgrade |
Other Non Operating Income (Expenses) | 19.79 | 77.32 | 23.18 | 10.58 | 0.29 | - | Upgrade |
EBT Excluding Unusual Items | 1.51 | 67.33 | -9.29 | -33.99 | -46.61 | -48.82 | Upgrade |
Merger & Restructuring Charges | -12.59 | -14.01 | -11.19 | -6.64 | -2.52 | -1.14 | Upgrade |
Impairment of Goodwill | -273.59 | -688.85 | -287.4 | - | - | - | Upgrade |
Other Unusual Items | 2 | 1.78 | -0.3 | -1.25 | -13.64 | -2.64 | Upgrade |
Pretax Income | -282.67 | -633.75 | -308.18 | -41.88 | -62.77 | -52.6 | Upgrade |
Income Tax Expense | -15.8 | -42.3 | -18.55 | -17.7 | -0.44 | - | Upgrade |
Earnings From Continuing Operations | -266.87 | -591.45 | -289.63 | -24.18 | -62.32 | -52.6 | Upgrade |
Minority Interest in Earnings | 78.18 | 178.32 | 87.24 | 16.96 | 10.42 | - | Upgrade |
Net Income | -188.69 | -413.12 | -202.39 | -7.22 | -51.91 | -52.6 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | -34.07 | -52.6 | Upgrade |
Net Income to Common | -188.69 | -413.12 | -202.39 | -7.22 | -17.84 | - | Upgrade |
Shares Outstanding (Basic) | 110 | 117 | 113 | 101 | 92 | 128 | Upgrade |
Shares Outstanding (Diluted) | 110 | 117 | 113 | 101 | 92 | 128 | Upgrade |
Shares Change (YoY) | -6.35% | 3.44% | 11.52% | 10.01% | -28.01% | 0.70% | Upgrade |
EPS (Basic) | -1.72 | -3.54 | -1.79 | -0.07 | -0.19 | - | Upgrade |
EPS (Diluted) | -1.72 | -3.54 | -1.79 | -0.07 | -0.19 | - | Upgrade |
Free Cash Flow | 36.01 | 45.85 | 38.21 | 27.25 | 18.48 | 21.82 | Upgrade |
Free Cash Flow Per Share | 0.33 | 0.39 | 0.34 | 0.27 | 0.20 | 0.17 | Upgrade |
Gross Margin | 83.91% | 83.87% | 86.18% | 88.38% | 88.31% | 90.63% | Upgrade |
Operating Margin | -5.59% | -3.86% | -12.29% | -16.24% | -12.66% | -10.23% | Upgrade |
Profit Margin | -77.88% | -163.81% | -80.50% | -3.24% | -10.74% | - | Upgrade |
Free Cash Flow Margin | 14.86% | 18.18% | 15.20% | 12.24% | 11.12% | 18.44% | Upgrade |
EBITDA | 41.81 | 41.93 | 20.84 | 20.75 | 38.92 | 47.47 | Upgrade |
EBITDA Margin | 17.26% | 16.62% | 8.29% | 9.32% | 23.42% | 40.12% | Upgrade |
D&A For EBITDA | 55.35 | 51.67 | 51.75 | 56.9 | 59.95 | 59.58 | Upgrade |
EBIT | -13.54 | -9.74 | -30.91 | -36.15 | -21.03 | -12.11 | Upgrade |
EBIT Margin | -5.59% | -3.86% | -12.29% | -16.24% | -12.66% | -10.23% | Upgrade |
Advertising Expenses | - | 1.9 | 1.6 | 1.6 | 0.9 | 0.6 | Upgrade |
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.